(c) 2024 PillSync.com

Lamivudine 100 MG Oral Tablet

1 INDICATIONS & USAGE Lamivudine tablets (HBV) are indi cat ed for the t r e atm ent of ch ronic h ep atitis B vi rus ( H B V) in f ection asso ci at ed with evid e n ce of h ep atitis B vi ral r epli c ation and active liv er in f l amm ation [s ee Clini cal Studi es ( 14.1 , 14.2 ) ] . The follo wing points sh ould be consid ered wh en initi ating th era py with lamivudine tablets (HBV): Due to hi gh rat es of resi st an ce d e v elopm ent in t r e at ed p ati ents, initi ation of t reatm ent with lamivudine tablets (HBV) should only be consid e r ed wh en the use of an alt e rn ative ant ivi ral a g ent with a hi gh er g en etic b arri er to r esist an ce is not av ail able or app rop ri a t e. Lamivudine tablets (HBV) h ave not b e en ev alu a t ed in p ati ents co -in fect ed with H I V, h e p atitis C vi rus (HC V), or h e p atitis d elta vi rus. Lamivudine tablets (HBV) h ave not b e en ev alu a t ed in liv er t ra nspl ant recipi ents or in p a ti ents with ch ronic h ep atitis B vi rus in fecti on with d ecomp ens at ed l iv er dis eas e. • Lamivudine tablets (HBV) are a nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation. (1)

camber pharmaceuticals, inc.

4 years ago OVAL PINK I 37 Lamivudine 100 MG Oral Tablet



LAMIVUDINE tablets (HBV), 100 mg are pink colored, capsule shaped, biconvex, film coated tablets, debossed with ‘37’ on one side and ‘I’ on the other side. Bottle of 60 tablets NDC 31722--752-60 Bottle of 600 tablets NDC 31722--752-06 Blister card of 10 Unit-dose tablets NDC 31722--752-31 Blister pack of 100 (10x10) Unit-dose tablets NDC 31722--752-32 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Preserve in well-closed, light-resistant containers.

More pills like OVAL I 37


"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site